申请人:CONCERT PHARMACEUTICALS INC
公开号:WO2009094210A1
公开(公告)日:2009-07-30
This invention relates to novel quinazoline derivatives and their acceptable acid addition salts. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by inhibitory activity against the VEGF receptor tyrosine kinase.